IACP Breaking News
IACP’s Efforts to Change DEA Policy on Constructive Transfer Focus of Law360 Article
9/27/12 -- As part of its efforts to change the Drug Enforcement Administration’s (DEA) policy regarding constructive transfer, IACP has been working with the media to bring light to this crucial problem. Last week, Law360 reporter, Rachel Slajda, accurately captured the situation in an insightful article, “Pharmacies Ill-Prepared for Potential DEA Crackdown.” IACP’s David G. Miller, RPh, Executive Vice President & CEO, shared the pharmacy compounding profession’s concerns regarding current DEA policy which places pharmacists in the untenable position of preparing and dispensing a controlled substance for a patient with no legal means of delivering it to the prescribing practitioner. The industry has been urging for a change in policy since 2010.
“The DEA is essentially unwilling to cooperate with the pharmacy equivalent of the American Medical Association...This isn’t some small little local handful of pharmacists complaining; this has massive scope,” he said. “I find it frustrating that when the profession is trying to solve a problem that impacts patients, when we are trying to work with the agency to solve it, they are unwilling.”
Click here to read the Law360 article in its entirety.
Return to IACP Home Page